Research Article
Pharmacokinetics and Toxicokinetics of Artemisinin-Hydroxychloroquine Sulfate Tablets in Rats and Dogs
Table 2
Pharmacokinetic parameters of hydroxychloroquine and artemisinin in rats after oral administration.
| | Parameters | Hydroxychloroquine | Artemisinin | | Female | Male | | Low-dose | Mid-dose | High-dose | Low-dose | Mid-dose | High-dose | Low-dose | Mid-dose | High-dose |
| | Cmax (ng/mL) | 402.6 ± 131.7 | 623.4 ± 114.0 | 868.5 ± 261.6 | 357.3 ± 259.3 | 534.0 ± 236.5 | 679.0 ± 570.6 | 35.0 ± 27.5 | 69.8 ± 71.2# | 46.2 ± 33.4 | | Tmax (h) | 3.9 ± 1.6 | 5.0 ± 1.1 | 5.8 ± 3.2 | 0.63 ± 0.60 | 0.50 ± 0.35 | 0.69 ± 0.38 | 0.63 ± 0.60 | 0.33 ± 0.20 | 0.44 ± 0.38 | | t1/2 (h) | 9.7 ± 2.7 | 11.0 ± 2.0 | 14.8 ± 4.5 | 0.73 ± 0.14 | 0.69 ± 0.17 | 2.17 ± 1.92 | 1.30 ± 1.62 | 0.71 ± 0.47 | 1.55 ± 0.94 | | MRT0−∞ (h) | 13.6 ± 2.9 | 16.2 ± 1.5 | 22.5 ± 5.3 | 1.24 ± 0.19 | 1.41 ± 0.21 | 3.59 ± 1.87 | 1.97 ± 2.25 | 0.81 ± 0.38# | 2.17 ± 1.64 | | Vd (mL/kg) | 153.2 ± 80.3 | 160.3 ± 22.0 | 203.1 ± 43.6△ | 115.1 ± 43.0 | 151.9 ± 90.7 | 562.6 ± 669.4 | 4238 ± 6741 | 3378 ± 1706# | 8314 ± 6234# | | CL (mL/h/kg) | 10.5 ± 2.4 | 10.2 ± 1.1 | 10.0 ± 2.8 | 112.9 ± 48.4 | 146.1 ± 65.9 | 148.2 ± 64.6 | 1564 ± 857# | 4873 ± 3511 | 4356 ± 4032 | | AUC0−t (h × ng/mL) | 5006.8 ± 1020.4 | 9829.5 ± 940.7 | 19925.3 ± 4291.6 | 407.1 ± 169.6 | 655.7 ± 308.0 | 1294.5 ± 797.0 | 30.2 ± 26.8# | 43.4 ± 59.6# | 44.0 ± 32.8# | | AUC0−∞ (h × ng/mL) | 5174.0 ± 966.7 | 10373.7 ± 1107.5 | 22419.7 ± 5599.7 | 416.2 ± 177.0 | 658.7 ± 306.2 | 1335.8 ± 761.2 | 34.5 ± 23.0# | 46.4 ± 63.6# | 64.4 ± 43.4# |
|
|
∗ significant difference from low-dose, significant difference from mid-dose, and significant difference from female. |